Two biotechs cut staff; AbbVie weathers biosimilar threat
Today, a brief rundown of news from AbbVie and AstraZeneca as well as updates from Glycomimetics, Cue Biopharma and Confo Therapeutics that you may have missed. AbbVie on Thursday reported second quarter results indicating it is weathering growing …